[1] |
Hillenbrand T, Menge F, Hohenberger P, et al. Primary and secondary angiosarcomas: a comparative single⁃center analysis[J]. Clin Sarcoma Res, 2015, 5: 14. DOI: 10.1186/s13569⁃015⁃0028⁃9.
|
[2] |
冯自豪, 刘家祺, 陆南杭, 等. 老年人头面部血管肉瘤七例分析[J]. 中华皮肤科杂志, 2013, 46(9): 665⁃667. DOI: 10.3760/cma.j.issn.0412⁃4030.2013.09.016.
|
|
Feng ZH, Liu JQ, Lu NH, et al. Angiosarcoma of the face and scalp in the elderly:an analysis of seven cases. Chin J Dermatol, 2013, 46(9): 665⁃667. DOI: 10.3760/cma.J.issn.0412⁃4030.2013.09.016.
|
[3] |
Torres KE, Ravi V, Kin K, et al. Long⁃term outcomes in patients with radiation⁃associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer[J]. Ann Surg Oncol, 2013, 20(4): 1267⁃1274. DOI: 10.1245/s10434⁃012⁃2755⁃y.
|
[4] |
Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment[J]. Cancer, 1987, 59(5): 1046⁃1057. DOI: 10.1002/1097⁃0142(19870301)59:5<1046::AID⁃CNCR2820590533>3.0.CO;2⁃6.
|
[5] |
Gollob JA, Veenstra KG, Parker RA, et al. Phase I trial of concurrent twice⁃weekly recombinant humaninterleukin⁃12 plus low⁃dose IL⁃2 in patients with melanoma or renal cell carcinoma[J]. J Clin Oncol, 2003, 21(13): 2564⁃2573. DOI: 10.1200/JCO.2003.12.119.
|
[6] |
Compton CC, Byrd DR, Garcia⁃Aguilar J, et al. AJCC Cancer Staging Atlas[M]. 2nd ed. New York, Springer Science+Business Media. 2012: 357⁃412. DOI: 10.1007/978⁃1⁃4614⁃2080⁃4.
|
[7] |
Mendenhall WM, Mendenhall CM, Werning JW, et al. Cutaneous angiosarcoma[J]. Am J Clin Oncol, 2006, 29(5): 524⁃528. DOI: 10.1097/01.coc.0000227544.01779.52.
|
[8] |
陈柳青, 曾学思, 姜祎群, 等. 9例老年人头面部血管肉瘤临床病理分析[J]. 临床皮肤科杂志, 2005, 34(11): 722⁃725. DOI: 10.3969/j.issn.1000⁃4963.2005.11.003.
|
|
Chen LQ, Zeng XS, Jiang YW, et al. Cutaneous angiosarcoma on face and scalp of the aged:clinical and pathological study of nine cases. J Clin Dermatol, 2005, 34(11): 722⁃725. DOI: 10.3969/j.issn.1000⁃4963.2005.11.003.
|
[9] |
Cuda J, Mirzamani N, Kantipudi R, et al. Diagnostic utility of Fli⁃1 and D2⁃40 in distinguishing atypical fibroxanthoma from angiosarcoma[J]. Am J Dermatopathol, 2013, 35(3): 316⁃318. DOI: 10.1097/DAD.0b013e318266b197.
|
[10] |
Fedok FG, Levin RJ, Maloney ME, et al. Angiosarcoma: current review[J]. Am J Otolaryngol, 1999, 20(4): 223⁃231. DOI: 10.1016/S0196⁃0709(99)90004⁃2.
|
[11] |
Morrison WH, Byers RM, Garden AS, et al. Cutaneous angio⁃sarcoma of the head and neck. A therapeutic dilemma[J]. Cancer, 1995, 76(2): 319⁃327. DOI: 10.1002/1097⁃0142(19950715)76:2<319::AID⁃CNCR2820760224>3.0.CO;2⁃8.
|
[12] |
Ohguri T, Imada H, Nomoto S, et al. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin⁃2 immunotherapy[J]. Int J Radiat Oncol Biol Phys, 2005, 61(5): 1446⁃1453. DOI: 10.1016/j.ijrobp.2004.08.008.
|
[13] |
Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosar⁃coma: a multivariate analysis of 55 cases[J]. J Surg Oncol, 1996, 61(3): 170⁃176. DOI: 10.1002/(SICI)1096⁃9098(199603)61:3<170::AID⁃JSO2>3.0.CO;2⁃8.
|